An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014–2022) Following the Introduction of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older
| Published in: | Drug Safety Vol. 47; no. 4; pp. 365 - 376 |
|---|---|
| Main Authors: | , , , |
| Format: | Journal Article |
| Published: |
Springer Nature
Apr2024
|
| Online Access: | View this record in EBSCOhost |
| Description not available. |